DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Roy A, Kish JK, Bloudek L. et al.
Estimating the costs of therapy in patients with relapsed and/or refractory multiple myeloma: a model framework.
Am Health Drug Benefits 2015;
8: 204-215
Access:
We do not assume any responsibility for the contents of the web pages of other providers.